Optimization of a transmural care pathway for allergen immunotherapy to primary care by an integrated personal eHealth environment

Abstract

AA and MS do not have any financial disclosures to report. MSF reports receiving a grant to her institution from AllerGenis, LLC. AG reports receiving consultant fees from N-Fold, LLC. FB and JMB are permanent employees of Beckman Coulter Life Sciences. RA at the time of the study was a PhD student employed by Beckman Coulter Life Sciences and recipient of a CIFRE grant from the ANRT (grant #2015/0384). HS reports being a part-time employee of DBV Technologies; receiving consultant fees from N-Fold LLC and Siolta Therapeutics; receiving grants to his institution from the National Institute of Allergy and Infectious Diseases (NIAID/NIH) and Immune Tolerance Network; receiving non-financial support from Beckman Coulter Life Sciences.